Search filters

List of works by Agnieszka Latosińska

Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation

scientific article published on 18 February 2016

CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID-19: A potential link to molecular pathophysiology?

scientific article published on 21 August 2021

CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer

scientific article published on 16 May 2019

Clinical Proteomics for Precision Medicine: The Bladder Cancer Case

scientific article published on 5 October 2017

Clinical Proteomics on the Path Toward Implementation: First Promises Delivered

scientific article published on 01 March 2019

Clinical Proteomics: Closing the Gap from Discovery to Implementation

scholarly article by Maria Frantzi published in July 2018

Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on bladder cancer

scientific article published on December 1, 2013

Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development

scientific article published on 29 March 2014

Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis

scientific article

Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine

scientific article published on 24 July 2015

Developing proteomic biomarkers for bladder cancer: towards clinical application

scientific article published on 26 May 2015

Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings

scientific article published on 11 May 2016

Optimized procedure of extraction, purification and proteomic analysis of nuclear proteins from mouse brain

scientific article published on 14 December 2015

Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: The past, the present, and the future

scientific article published on 14 May 2019

Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease

scientific article published on 17 April 2018

Promise and Implementation of Proteomic Prostate Cancer Biomarkers

scientific article published on 29 August 2018

Proteome-based classification of Nonmuscle Invasive Bladder Cancer

scientific article published on 26 July 2019

Proteomics and Metabolomics for AKI Diagnosis.

scientific article published in January 2018

Proteomics biomarkers for solid tumors: Current status and future prospects

scientific article published on 11 June 2018

Proteomics in Drug Development: The Dawn of a New Era?

scientific article published on 25 February 2019

Recent progress in urinary proteome analysis for prostate cancer diagnosis and management

scientific article

Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles

scientific article published on 26 July 2017

Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models

scientific article published on 23 September 2016

Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment.

scientific article published on 16 May 2019

Targeting the proteome of cellular fractions: focus on secreted proteins

scientific article

Urinary CE-MS peptide marker pattern for detection of solid tumors

scientific article published on 27 March 2018

Urinary proteomic biomarkers in oncology: ready for implementation?

scientific article published on 15 November 2018

Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups

scientific article published on 16 January 2017

Value of Urine Peptides in Assessing Kidney and Cardiovascular Disease

scientific article published on 25 July 2020